Abstract | OBJECTIVE: PATIENTS AND METHODS: The study included 45 patients with bladder TCC; VEGF-C expression was assessed by immunohistochemistry and the association between VEGF-C expression and angiogenesis, as evaluated by microvessel density (MVD), was examined. RESULTS: There was VEGF-C expression in the cytoplasm of tumour cells, but very little in the normal transitional epithelium. VEGF-C expression was significantly associated with tumour size, pathological T stage, pathological grade, lymphatic-venous involvement and pelvic lymph node metastasis (all P < 0.05). Multivariate analysis showed that VEGF-C expression was an exclusive independent factor influencing pelvic lymph node metastasis. Moreover, the patients with high VEGF-C expression had a markedly poorer prognosis than those with no or low VEGF-C expression (P = 0.014). A multivariate analysis based on the Cox proportional hazard model showed that lymph node metastasis was only an independent prognostic factor in the multivariate analysis using the Cox regression model (P = 0.010). CONCLUSION:
|
Authors | Xiongbing Zu, Zhengyan Tang, Yuan Li, Ning Gao, Jian Ding, Lin Qi |
Journal | BJU international
(BJU Int)
Vol. 98
Issue 5
Pg. 1090-3
(Nov 2006)
ISSN: 1464-4096 [Print] England |
PMID | 17034609
(Publication Type: Journal Article)
|
Chemical References |
- Vascular Endothelial Growth Factor C
|
Topics |
- Adult
- Aged
- Carcinoma, Transitional Cell
(pathology)
- Disease-Free Survival
- Humans
- Immunohistochemistry
- Lymphatic Metastasis
- Middle Aged
- Neovascularization, Pathologic
- Prognosis
- Urinary Bladder Neoplasms
(pathology)
- Vascular Endothelial Growth Factor C
(metabolism)
|